KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2016 - 2025)

Inovio Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.0 for Q2 2025.

  • For Q2 2025, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM value through Jun 2025 reached 0.0, changed N/A, while the annual FY2024 figure was 0.0, 52.15% down from the prior year.
  • Asset Utilization Ratio for Q2 2025 was 0.0 at Inovio Pharmaceuticals, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.04 in Q2 2023 and bottomed at 0.0 in Q3 2024.
  • The 5-year median for Asset Utilization Ratio is 0.0 (2023), against an average of 0.01.
  • The largest YoY upside for Asset Utilization Ratio was 871.97% in 2023 against a maximum downside of 84.46% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then surged by 705.63% to 0.03 in 2022, then crashed by 83.51% to 0.0 in 2023, then crashed by 56.74% to 0.0 in 2024, then rose by 18.6% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for INO's Asset Utilization Ratio are 0.0 (Q2 2025), 0.0 (Q1 2025), and 0.0 (Q4 2024).